India's Clinical Trials advantage is relative. Less than 2% of the world's trials are conducted there, while the majority goes to the US, Europe, Latin America, and South Southeast Asia. This is because other economies offer a high patient population and cost advantages to companies.

For example, companies in China, S Korea, Taiwan, and Poland can save up to 60% of their costs by outsourcing Clinical Trials.

A randomized and double-blinded Clinical Trials has a number of advantages over other types of trials. For one, blinding and randomization remove confounding factors, which may influence the results of a trial. Secondly, randomization removes physician-induced bias, which may have a negative impact on the study.

The outcome of the trial will be as representative of the general population as possible, and doctors are less likely to be biased or affected by factors that are unrelated to the treatment.

Double-blind trials to eliminate the "power of suggestion" that can influence the outcome of a study. In a double-blind trial, no one except the researchers knows which treatment the patients receive. Thus, the study results will not be affected by the doctors' beliefs or personal preferences.

Another benefit of randomized and double-blinded trials is their ability to demonstrate causality. However, they can be expensive to run. However, it is well worth the investment, as they provide more answers and can prove the effectiveness of a treatment over placebos.